Monoclonal antibodies specific to VEGF receptors and uses thereof
US6365157B2 · kind B2 · utility
50Cited by
4References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1999 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | Sep 22, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies that specifically bind to an extracellular domain of a flt-1 receptor and neutralize activation of the receptor are provided. In vitro and in vivo methods of using these antibodies are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.